Mirikizumab
Drug Details
- Generic Name
- Mirikizumab
- Brand Names
- N/A
- Application Number
- Sponsor
- Eli Lilly Kinsale Limited
- NDC Codes
- 1
- Dosage Forms
- LIQUID
- Routes
- N/A
- Active Ingredients
- MIRIKIZUMAB
Indications and Usage
1 INDICATIONS AND USAGE OMVOH is indicated for the treatment of: moderately to severely active ulcerative colitis in adults. moderately to severely active Crohn's disease in adults. OMVOH TM is an interleukin-23 antagonist indicated for the treatment of: moderately to severely active ulcerative colitis in adults ( 1 ) moderately to severely active Crohn's disease in adults ( 1 )